RxDoctor Payments Data

Christine Mirabal, MD

Otolaryngology · Pine Bluff, ARNPI 1831338730

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Medtronic at 29.9% of the total. Reporting peaked in 2022 at $532 and has fallen 89.9% since, to $54 in 2025.

$1,727in general payments, 2019–2025

Across 65 payments — averaging $26.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$516
  • Stryker$289
  • Optinose US, Inc.$263
  • GSK$250
  • Intersect ENT, Inc.$163
  • Sanofi$61
  • plus $185 from 7 others

What the payments were for

  • Food & beverage$1,727100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,727 in reported general payments places this provider in the 65th percentile of 72 otolaryngology providers in Arkansas.

See all otolaryngology providers in Arkansas

Medicare billing

Part B allowed, 2024
$85,467
Medicare patients
338
Services billed
995

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth42$4,755
Fluticasone Propionate104$1,315
Ofloxacin43$1,127
Azelastine Hcl44$973
Ipratropium Bromide19$447
Methylprednisolone54$442
Mupirocin35$329
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav27$271
Doxycycline Monohydrate16$210
Pantoprazole Sodium29$193
Nystatin13$190
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim40$180
Fluconazole16$153
Azithromycin38$143
Montelukast Sodium27$109

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Pine Bluff

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →